A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) - a randomised feasibility study using the trial within a cohort (TwiC) methodology.
Anna C BibbyNatalie Zahan-EvansEmma KeenanCharles CominsJohn E HarveyHelen DayNajib M RahmanJanet E FallonRachael Gooberman-HillNick A MaskellPublished in: Pilot and feasibility studies (2022)
TILT was registered prospectively on the European Clinical Trials Registry (EudraCT number 2016-004727-23 ) and the ISRCTN Register ( 10432197 ) on 04 December 2017.